Frontiers in Psychiatry | Psychopharmacology

Original Research

Published on 06 Oct 2023

Paliperidone long-acting injection in the treatment of an adolescent with schizophrenia with fluctuating mental symptoms during menstrual period: a case report

in Psychopharmacology

Feng Wang
Juan Chen
Linglin Guo
Zhixiong Li
Zhe Li

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1276983

3,610 views
1 citation

Original Research

Published on 03 Oct 2023

Dose-dependent QTc interval prolongation under haloperidol and pipamperone in the management of delirium in a naturalistic setting

in Psychopharmacology

Philipp Bohny
Soenke Boettger
Josef Jenewein

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1257755

3,348 views
4 citations

Systematic Review

Published on 22 Sep 2023

Cardiovascular adverse reactions associated with escitalopram in patients with underlying cardiovascular diseases: a systematic review and meta-analysis

in Psychopharmacology

Kenichi Kimura
Hisashi Narita
Hissei Imai
Hisashi Akiyama
Shuhei Ishikawa
Ryo Sawagashira
Tomoyuki Isoyama
Mariko Nohara
Michiyo Kawamura
Yukari Kono

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1248397

17,294 views
3 citations

Perspective

Published on 20 Sep 2023

Lifeboat ethics, risk, and therapeutic opportunity: an appeal for equitable psychedelic therapy access in the “high-risk” addiction patient

in Psychopharmacology

Taylor Black

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1159843

3,879 views
1 citation

Original Research

Published on 19 Sep 2023

Naturalistic psilocybin use is associated with persisting improvements in mental health and wellbeing: results from a prospective, longitudinal survey

in Psychopharmacology

Sandeep M. Nayak
Hillary Jackson
Nathan D. Sepeda
David S. Mathai
Sara So
Abigail Yaffe
Hadi Zaki
Trey J. Brasher
Matthew X. Lowe
Del R. P. Jolly

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1199642

52,753 views
51 citations

Methods

Published on 19 Sep 2023

The Montreal model: an integrative biomedical-psychedelic approach to ketamine for severe treatment-resistant depression

in Psychopharmacology

Nicolas Garel
Jessica Drury
Julien Thibault Lévesque
Nathalie Goyette
Alexandre Lehmann
Karl Looper
David Erritzoe
Shannon Dames
Gustavo Turecki
Soham Rej

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1268832

18,163 views
12 citations

Original Research

Published on 15 Sep 2023

Effects of smoking cessation on plasma clozapine concentrations in male patients with schizophrenia during the COVID-19 pandemic

in Psychopharmacology

Botao Ma
Hongzhen Fan
Siyuan Qi
Fude Yang
Huimei An

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1256264

2,610 views

Original Research

Published on 30 Aug 2023

Reductions in anxiety and depression symptoms in a subset of outpatients with problematic substance use who received ketamine-assisted psychotherapy: a two-year retrospective chart review

in Psychopharmacology

Emily Whinkin
Therry Rose J. Eparwa
Michelle C. Julseth
Andrea Schneider
Sunil K. Aggarwal

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1160442

4,259 views
1 citation

Editorial

Published on 21 Aug 2023

Editorial: Community series in novel antipsychotics within and beyond clinical trials: symptom-based treatment of psychiatric disorders with D3-D2 partial agonists, volume II

in Psychopharmacology

Peter Falkai
Zsófia Borbála Dombi

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1266566

1,511 views

Original Research

Published on 21 Aug 2023

Individually tailored dosage regimen of full-spectrum Cannabis extracts for autistic core and comorbid symptoms: a real-life report of multi-symptomatic benefits

in Psychopharmacology

Patrícia Soares Silva Montagner
Wesley Medeiros
Leandro Cruz Ramires da Silva
Clarissa Nogueira Borges
Joaquim Brasil-Neto
Vinícius de Deus Silva Barbosa
Fabio V. Caixeta
Renato Malcher-Lopes

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1210155

13,080 views
12 citations

Editorial

Published on 14 Aug 2023

Editorial: Bridging the gap: an interdisciplinary perspective on ketamine in psychiatric disorders

in Psychopharmacology

Glenn Hartelius
Sherry-Anne Muscat
Lucie Bartova

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1246891

3,378 views
3 citations

Case Report

Published on 07 Aug 2023

Case report: application of pharmacogenetics in the personalized treatment of an elderly patient with a major depressive episode

in Psychopharmacology

Milica Pjevac
Sara Redenšek Trampuž
Tanja Blagus
Vita Dolžan
Jurij Bon

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1250253

4,711 views
2 citations

Systematic Review

Published on 04 Aug 2023

Magnitude of placebo response in clinical trials of paroxetine for vasomotor symptoms: a meta-analysis

in Psychopharmacology

Joshua R. Rhodes
Cameron T. Alldredge
Gary R. Elkins

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1204163

4,076 views
3 citations

Case Report

Published on 31 Jul 2023

A case report—“When less is more”: controlled inpatient reduction of anticholinergic burden in a patient with clozapine-resistant schizophrenia

in Psychopharmacology

Milica Pjevac
Liam Korošec Hudnik

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1222177

3,004 views
3 citations

Case Report

Published on 27 Jul 2023

Case report: Hyperactive delirium after a single dose of zolpidem administered additionally to psychopharmacotherapy including clozapine

in Psychopharmacology

Maximilian Preiss
Ulrich Rabl
Valentin Popper
Victoria Watzal
Michael Treiber
Dominik Ivkic
Nicole Praschak-Rieder
Angela Naderi-Heiden
Gernot Fugger
Richard Frey

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1204009

3,448 views
3 citations

Original Research

Published on 14 Jul 2023

Attitudes, beliefs, and knowledge regarding medical cannabis among healthcare students in the Republic of Cyprus: a cross-sectional descriptive correlational study

in Psychopharmacology

Sokratis Sokratous
Meropi Mpouzika
Katerina Kaikoushi
George Alexandrou
Maria Karanikola

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1196915

4,143 views
1 citation